Levels of STK4 were selectively reduced in HPV+ cervical cancer lines and these findings were supported by clinical data, showing that STK4 expression negatively correlates with cervical disease progression and is markedly down regulated in cervical cancer. This evidence concerns the gene STK4 and cervical carcinoma.